Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-28T16:34:18.755Z Has data issue: false hasContentIssue false

Affective and physiological responses to human body odors in social anxiety – a pilot study on the possible effects as catalyst for treatment

Published online by Cambridge University Press:  19 July 2023

E. Vigna*
Affiliation:
National Centre for Suicide Research and Prevention of Mental Ill-Health, Karolinska Institutet, Solna, Sweden
C. Cecchetto
Affiliation:
Department of General Psychology, University of Padova, Padova, Italy
E. Dal Bò
Affiliation:
Department of General Psychology, University of Padova, Padova, Italy
G. Hadlaczky
Affiliation:
National Centre for Suicide Research and Prevention of Mental Ill-Health, Karolinska Institutet, Solna, Sweden
D. Wasserman
Affiliation:
National Centre for Suicide Research and Prevention of Mental Ill-Health, Karolinska Institutet, Solna, Sweden
V. Carli
Affiliation:
National Centre for Suicide Research and Prevention of Mental Ill-Health, Karolinska Institutet, Solna, Sweden
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Understanding the way chemistry influences human communication is important since the reaction to chemosignals has many implications for science and society.

Numerous research points out that human beings are able to identify feelings of fear and happiness through smell. Such emotional information can lead to approach-avoidance behaviors or changes in affective state. Moreover, a heightened sensitivity to social odors has been shown in subjects with social anxiety symptoms. However, more detailed research on the connection between olfaction, affective psychiatric disorders and interpersonal social communication is required.

POTION is an EU funded project within the Horizon2020 initiative that aims at understanding the nature of chemosignals in humans and their sphere of influence on social interaction. Whitin this project, we conducted a preliminary study showing that individuals with social anxiety symptoms benefited from mindfulness training especially when exposed to social chemosignals. A significant reduction in anxiety symptoms was achieved with both the happiness (t(25)=4.37, p=0.029) and the fear (t(25)=4.35, p=0.031) chemosignals. Moreover, individuals exposed to the happiness chemosignal exhibit highier vagal tone compared to subjects exposed to fear chemosignals (p = 0.026), indicating overall increased well-being.

Objectives

Given the exploratory nature of the preliminary study, an hypothesis driven pilot-RCT with larger sample size and refined design has been conducted. The aim was to further explore the catalyst effect of body odor on anxiety reduction. Notably, if the odor groups (happiness, fear or neutral) differ with the control group (clean air) and if they differ between each other in the outcome measure.

Methods

To this end, 96 participants with social anxiety symptoms (women aged between 18 to 35) were randomly allocated to one exposure group (happiness, fear or neutral human body odor or clean air) and followed a mindfulness intervention while being exposed to the odor. Psychological outcomes were measured before and after the intervention through the State-Trait Anxiety Inventory. During the intervention participants’ skin conductance and heart rate was also measured.

Analysis of variance will be performed to assess psychological outcome differences between and within groups, as well as interactions (GroupxTime).

Results

Results of the study will be available and presented at the time of the congress.

Conclusions

This study represents an advancement in the field mental health as it explores the potential impact of using human chemosignals in the clinical setting.

Disclosure of Interest

None Declared

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.